• SENSEX
    NIFTY 50
big story

Decoding Lok Sabha election results 2019: 6 reasons how the verdict became a pro-incumbency vote

272/543
L :0
W :353
L :0
W :92
NDA :353
UPA : 92
LOK SABHA ELECTION RESULTS 2019
Total Constituencies
543
Voter Turnout
67.11%
NDA : 353
2014 : 354 Seats
BJP
303
+
SS
18
+
Other
32
UPA : 92
2014 : 66 Seats
INC
52
+
DMK
23
+
Other
17
OTH : 97
2014 : 107 Seats
TMC
22
+
YSRCP
22
+
Other
53
VIDEOS
Market

Sudarshan Sukhani on December 6: Buy UPL, & Jubilant Foodworks; Sell JSW Steel

Updated : December 06, 2018 11:45 AM IST

The latest analysis and commentary by stock market guru Sudarshan Sukhani on what is moving the markets today. Check out his top stock recommendations.

He spoke at length about Tata Steel, Tata Motors, Balkrishna Industries, UPL, Divis Laboratories, Tata Steel, Sun Pharmaceutical, UPL, Jubilant Foodworks, JSW Steel.

Recommending specific stocks ideas, Sukhani said, “UPL is outperforming. It was in my list in the morning also and I think that continues. I would say go and buy UPL. Second is Jubilant Foodworks. I guess people need those fast foods even more when there is slight disturbance and turbulence. So Jubilant Food is a buying opportunity. All metals are short sells, so for now JSW Steel is a short sell, but you could sell Vedanta, Hindalco, Tata Steel, anything.”

Speaking about the individual stock ideas, Sukhani said, “Tata Steel is a short sell. Metals are now going into a bear market, these are not buy on dips opportunity; Hindalco, Tata Steel look like as if some major declines are coming. So Tata Steel is a short for the day, even on a gap down, on small intraday rally you can go and sell it. I have been hearing how Tata Motors bottomed out at Rs 500, Rs 400, Rs 300, Rs 200, I suspect that story will continue when it goes into double digits. It is a short sell. Balkrishna Industries has been underperforming all other similar companies, Ceat or Apollo Tyres or others; that is a short.”

“If the market stabilizes, UPL is a buy. The stock is outperforming. Pharmaceutical will outperform despite Sun Pharmaceutical. So, Divis Laboratories is a buy. There is no rush, maybe by mid-afternoon you will get these buys,” he added.

Follow stock recommendations by Sudarshan Sukhani here: https://www.cnbctv18.com/author/sudarshan-sukhani-159/

Disclaimer: The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.
primo org
Have you signed up for Primo, our daily newsletter?
It has all the stories and data on the market, business, economy and tech that you need to know.
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more
Live TV